Bank Of Montreal Novavax Inc Put Options Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $2.14 Million - $11.6 Million	-551,200 Reduced 84.8%	98,800 $1.25 Million
Q1 2024 May 13, 2024	SELL	$3.76 - $6.02 $752,000 - $1.2 Million	-200,000 Reduced 23.53%	650,000 $3.11 Million
Q4 2023 Feb 08, 2024	BUY	$4.8 - $7.67 $4.08 Million - $6.52 Million	850,000 New	850,000 $4.08 Million
Q2 2023 Aug 02, 2023	BUY	$6.67 - $9.52 $98,049 - $139,944	14,700 New	14,700 $109,000
Q1 2023 Jun 13, 2024	SELL	$5.76 - $12.48 $3.66 Million - $7.93 Million	-635,300 Reduced 97.74%	14,700 $101,000
Q2 2022 Aug 11, 2022	BUY	$36.28 - $75.29 $348,288 - $722,784	9,600 New	9,600 $510,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.